144 RTX-240, an allogeneic engineered red blood cell expressing 4–1BBL and IL-15TP, promotes NK cell functionality in vitro and in vivo

• Sivan Elloul,
• Anne-Sophie Dugast,
• Shannon McArdel,
• Enping Hong,
• Arjun Bollampalli,
• Maegan Hoover,
• Sneha Pawar,
• Viral Amin,
• Kangjian Qiao,
• Christopher Ta,
• Laurence Turka,
• Thomas Wickham

Affiliations

Sivan Elloul

Aff6 grid.417407.1Karyopharm Therapeutics Newton MA USA

Anne-Sophie Dugast

Rubius Therapeutics, Cambridge, MA, USA

Shannon McArdel

Rubius Therapeutics, Cambridge, MA, USA

Enping Hong

Rubius Therapeutics, Cambridge, MA, USA

Arjun Bollampalli

Rubius Therapeutics, Cambridge, MA, USA

Maegan Hoover

Rubius Therapeutics, Cambridge, MA, USA

Sneha Pawar

Rubius Therapeutics, Cambridge, MA, USA

Viral Amin

Rubius Therapeutics, Cambridge, MA, USA

Kangjian Qiao

Rubius Therapeutics, Cambridge, MA, USA

Christopher Ta

Rubius Therapeutics, Cambridge, MA, USA

Laurence Turka

Rubius Therapeutics, Cambridge, MA, USA

Thomas Wickham

Rubius Therapeutics, Cambridge, MA, USA